FORT WORTH, Texas, April 28, 2015 /PRNewswire/ -- Galderma, the company dedicated to skin health, announces two new leadership appointments today.
Kelly Huang, Ph.D. will join Galderma as Vice President and General Manager of the company's Aesthetic and Corrective Business Unit in the United States.
Chuck Paschke was named Senior Director of Organizational Health. Paschke has been with Galderma more than 18 years and most recently served as Galderma's Senior Director Leadership, Commercial Excellence.
Dr. Huang will oversee Galderma's Aesthetic and Corrective business, which includes a broad portfolio of treatments. Galderma is a global leader in Aesthetic medicine with two decades of expertise and 20 million Restylane® treatments received by patients. In May 2014, Galderma acquired the rights to distribute its products Restylane, Perlane®, Sculptra® and Dysport® in the U.S. and Canada, as well. The recently launched Restylane® Silk is the first and only FDA approved filler for lip enhancement and for the treatment of lines around the mouth in patients over the age of 21.
Dr. Huang holds Doctorate and Master's degrees in Chemical Engineering from Stanford University, as well as a Bachelor's degree in Chemical Engineering, with a minor in Chemistry, from the University of Massachusetts at Amherst.
Dr. Huang served Johnson & Johnson for 16 years, where he focused primarily on skincare, leading award-winning product launches in cosmetic and OTC products as Vice President of R&D, Professional Sales & Marketing, and as a Corporate Officer of J&J's Neutrogena Corporation. More recently, he served as President of Endo Pharmaceuticals' HealthTronics division, the urology device and services company, overseeing nearly a hundred physician partnerships delivering surgical services across the country, as well as for medical device R&D, manufacturing, and sales & marketing.
"With the promising debut of Restylane® Silk and other launches expected in the future, it's an ideal time for someone with Kelly's wealth of experience to join Galderma's growing organization," states Todd Zavodnick, President and General Manager of Galderma Laboratories, L.P.
"Galderma's unique vision for skin health, passionate people, and rich pipeline from a longstanding commitment to science make it a magnet in the industry. I look forward to improving patient lives by partnering with healthcare professionals to drive innovation and superior outcomes in Aesthetic medicine," says Kelly Huang.
Chuck Paschke's appointment as Senior Director of Organizational Health demonstrates Galderma's commitment to cultivating an environment that supports professional growth and healthy work-life balance for its employees. Paschke will lead the company's efforts to set new standards for organizational efficiency as a member of the Galderma's U.S. Leadership Team.
A healthy organization means employees are engaged, have high morale, and there is shared clarity on the business goals and growth opportunities. Chuck has already begun engaging with employees. His overall ambition is to focus on ensuring that the basic elements of Organizational Health are aligned and optimized. Those elements are: Listening, Productivity, Collaboration and Communication.
Chuck joined Galderma in February of 1997 as Director of Managed Care & Trade National Accounts. He has also served as Director of Sales, Vice President of Sales, and Senior Director Leadership, Commercial Excellence & Meeting Planning.
Chuck has worked in the pharmaceutical and healthcare field for more than 35 years and has an extensive working knowledge of internal and external customers. He holds a B.A. in Marketing/Management from Baldwin-Wallace University in Cleveland, Ohio.
"At Galderma, we are intently focused on creating an environment where our employees can do great work while enjoying doing it, advancing our company's mission and serving their personal and professional aspirations," said Chuck Paschke. "We will continue to foster opportunities to listen and understand employees and work toward creating a healthy organization as well as a great place to work."
In March 2015, Galderma announced several key organizational appointments, including the announcement of a new President and General Manager of Galderma Laboratories, L.P. Todd Zavodnick, who oversees U.S. operations organized in three business units: Prescription, Self-Medication, and Aesthetic and Corrective.
"These leadership announcements complete our team and enable us to serve healthcare providers, patients and consumers even better to meet growing skin health needs, while also focusing on our employees and their ability to find success and empowerment here at Galderma," states Todd Zavodnick. "It was strategically important to have a position fostering engagement."
Galderma, is committed to delivering innovative medical solutions to meet the dermatological needs of people throughout their lifetime while serving healthcare professionals around the world. The Company's extensive product portfolio is available in 80 countries and treats a range of dermatological conditions including: acne, rosacea, nail mycosis, psoriasis & steroid-responsive dermatoses, pigmentary disorders, skin cancer and medical solutions for skin senescence. Strategic brands include Epiduo, Oracea, Differin, Mirvaso, Soolantra, Tri-Luma, Loceryl, Benzac, Cetaphil, Excipial, Daylong, Metvix, Azzalure/ Dysport, Restylane and Emervel.